Polycystic Ovarian Syndrome Panel 2

Polycystic Ovarian Syndrome (PCOS) Panel 2

What it is

The Polycystic Ovarian Syndrome (PCOS) Panel 2 is an advanced set of blood tests that evaluates hormone levels and metabolic health in women suspected of having Polycystic Ovarian Syndrome. PCOS is a common endocrine disorder affecting women of reproductive age, linked to irregular periods, infertility, acne, weight gain, and excessive hair growth. Panel 2 usually includes a broader range of reproductive hormones and metabolic markers compared to Panel 1, offering a more detailed assessment.

Uses

This panel is used to confirm a diagnosis of PCOS, rule out other hormonal conditions, and evaluate associated metabolic risks. It helps doctors tailor treatment for menstrual irregularities, infertility, androgen-related symptoms (acne, hirsutism), and long-term risks like type 2 diabetes, obesity, and cardiovascular disease. It is especially useful for women with complex symptoms requiring a more comprehensive evaluation than PCOS Panel 1.

Symptoms That May Lead to the Test

Doctors may recommend PCOS Panel 2 if you experience:
– Irregular, absent, or heavy menstrual cycles.
– Infertility despite attempts to conceive.
– Excessive facial or body hair growth (hirsutism).
– Persistent acne, oily skin, or hair thinning.
– Rapid weight gain or obesity.
– Signs of insulin resistance such as dark skin patches (acanthosis nigricans).
– Family history of PCOS, diabetes, or metabolic syndrome.

Abnormal Results

High Androgens (Testosterone, DHEAS): Suggestive of PCOS-related hormonal imbalance.

Elevated LH/FSH Ratio: Often seen in PCOS, though not diagnostic alone.

Abnormal Insulin or Glucose Levels: Indicate insulin resistance or prediabetes, common in PCOS.

Dyslipidemia: Abnormal cholesterol or triglyceride levels may reflect increased cardiovascular risk.

Normal Results: Do not always exclude PCOS; diagnosis is based on a combination of test results, clinical symptoms, and imaging (ovarian ultrasound).

Risks

The test requires a routine blood draw. Risks are minimal and limited to mild pain, bruising, or dizziness at the puncture site. The analysis itself has no associated risks.